A phenotypic compound screening assay for lysosomal storage diseases

Journal of Biomolecular Screening

Volumn 19, Issue 1, 2014, Pages 168-175

  Xu, Miao ^a,b   Liu, Ke ^a   Swaroop, Manju ^a   Sun, Wei ^a   Dehdashti, Seameen J ^a   McKew, John C ^a   Zheng, Wei ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

cyclodextrin; enlarged lysosome; lysosomal storage diseases; Lysotracker; Niemann Pick disease type C

Indexed keywords

CHOLESTEROL; METHYL BETA CYCLODEXTRIN;

ARTICLE; CONTROLLED STUDY; FIBROBLAST; FIBROBLAST CULTURE; FLUORESCENCE; FLUORESCENCE IMAGING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50; LYSOSOME; LYSOSOME STORAGE DISEASE; LYSOTRACKER STAINING; NIEMANN PICK DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SKIN FIBROBLAST; STAINING;

CYCLODEXTRIN; ENLARGED LYSOSOME; LYSOSOMAL STORAGE DISEASES; LYSOTRACKER; NIEMANN PICK DISEASE TYPE C;

CELL LINE; CELL TRACKING; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; FLUORESCENT DYES; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; PHENOTYPE;

EID: 84890828068     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057113501197     Document Type: Article

References (15)

1. Schultz M. L., Tecedor L., Chang M., et al. Clarifying Lysosomal Storage Diseases. Trends Neurosci. 2011 ; 34: 401-410
2. Meikle P. J., Hopwood J. J., Clague A. E., et al. Prevalence of Lysosomal Storage Disorders. JAMA. 1999 ; 281: 249-254
3. Lachmann R. H.. Enzyme Replacement Therapy for Lysosomal Storage Diseases. Curr. Opin. Pediatr. 2011 ; 23: 588-593
4. Beutler E.. Lysosomal Storage Diseases: Natural History and Ethical and Economic Aspects. Mol. Genet. Metab. 2006 ; 88: 208-215
5. Smid B. E., Aerts J. M., Boot R. G., et al. Pharmacological Small Molecules for the Treatment of Lysosomal Storage Disorders. Expert Opin. Investig. Drugs. 2010 ; 19: 1367-1379
6. Beck M.. Emerging Drugs for Lysosomal Storage Diseases. Expert Opin. Emerg. Drugs. 2010 ; 15: 495-507
7. LaPlante J. M., Sun M., Falardeau J., et al. Lysosomal Exocytosis Is Impaired in Mucolipidosis Type IV. Mol. Genet. Metab. 2006 ; 89: 339-348
8. Medina D. L., Fraldi A., Bouche V., et al. Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance. Dev. Cell. 2011 ; 21: 421-430
9. Klein D., Bussow H., Fewou S. N., et al. Exocytosis of Storage Material in a Lysosomal Disorder. Biochem. Biophys. Res. Commun. 2005 ; 327: 663-667
10. Chen F. W., Li C., Ioannou Y. A.. Cyclodextrin Induces Calcium-Dependent Lysosomal Exocytosis. PLoS One. 2010 ; 5: e15054
11. Xu M., Liu K., Swaroop M., et al. delta-Tocopherol Reduces Lipid Accumulation in Niemann-Pick Type C1 and Wolman Cholesterol Storage Disorders. J. Biol. Chem. 2012 ; 287: 39349-39360
12. Haugland R. P. The Handbook: A Guide to Fluorescent Probes and Labeling Technologies. Haugland R. P. Spence M. T. Z. Johnson I. D., ed. Eugene, OR: Molecular Probes ; 2005: 580-583.
13. Cao Y., Staropoli J. F., Biswas S., et al. Distinct Early Molecular Responses to Mutations Causing vLINCL and JNCL Presage ATP Synthase Subunit C Accumulation in Cerebellar Cells. PLoS One. 2011 ; 6: e17118
14. Curcio-Morelli C., Charles F. A., Micsenyi M. C., et al. Macroautophagy Is Defective in Mucolipin-1-Deficient Mouse Neurons. Neurobiol. Dis. 2010 ; 40: 370-377
15. Swaroop M., Thorne N., Rao M. S., et al. Evaluation of Cholesterol Reduction Activity of Methyl-Beta-Cyclodextrin Using Differentiated Human Neurons and Astrocytes. J. Biomol. Screen. 2012 ; 17: 1243-1251